340B Drug Pricing Program
AHA 340B Advocacy Alliance Bulletin for September 15, 2022
Commenting today on the Centers for Medicare & Medicaid Services’ proposed calendar year 2023 payment rule for hospital outpatients and ambulatory surgical centers, AHA said it supports the agency’s decision to end its unlawful cuts to 340B hospitals and urged the agency to promptly restore…
With Sept. 19 quickly approaching, there are just a few days left to complete recertification for the Health Resources and Services Administration’s 340B program
The U.S. District Court for the District of Columbia should vacate the 2022 outpatient prospective payment system rule insofar as it sets a payment rate for 340B hospitals that is lower than the generally applicable payment rate of Average Sales Price plus 6%, AHA told the court yesterday.
AHA files reply brief as district court considers 340B payment remedy for the remainder of 2022.
The AHA weighs in on a number of issues of importance to hospitals and health systems, as well as the patients they care for, as they come before the court. Below are our most recent friend-of-the-court briefs.
The AHA Aug. 10 distributed to members a special bulletin encouraging hospitals to submit comments as soon as possible to the Centers for Medicare and Medicaid Services’ calendar year 2023 outpatient prospective payment system proposed rule.
The AHA Aug.
AHA yesterday asked the U.S. District Court for the District of Columbia to order the Department of Health and Human Services to immediately stop underpaying certain hospitals that participate in the 340B Drug Pricing Program and promptly repay them for the unlawful cuts since 2018 without…
The AHA today made a series of filings in district court to ensure that 340B hospitals are promptly repaid and that the rest of the hospital field is not penalized for the agency’s unlawful policy.